BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34365858)

  • 1. A Consideration for Surgical Management in Select T4b Oral Cavity Squamous Cell Carcinoma.
    Chen MM; Chang CM; Dermody S; Rosko AJ; Mierzwa ML; Swiecicki PL; Spector ME; Worden FP; Prince MEP; Chinn SB
    Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):609-616. PubMed ID: 34365858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic determinants of locally advanced buccal mucosa cancer: Do we need to relook the current staging criteria?
    Pillai V; Yadav V; Kekatpure V; Trivedi N; Chandrashekar NH; Shetty V; Rangappa V; Subramaniam N; Bhat V; Raghavan N; Kolur T; George N; Thomas T; Kuriakose MA
    Oral Oncol; 2019 Aug; 95():43-51. PubMed ID: 31345393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literature.
    Quinton BA; Cabrera CI; Tamaki A; Li S; Fowler N; Rezaee R; Lavertu P; Teknos T; Pan Q; Thuener J
    Am J Otolaryngol; 2022; 43(4):103511. PubMed ID: 35609426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-compliant adjuvant chemotherapy for resected high risk oral cavity cancer: Homefield advantage.
    Cherupalla B; Warren J; Kane A; Trendle M; Tassone P
    Am J Otolaryngol; 2024; 45(1):104051. PubMed ID: 37738883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Positive Surgical Margins in cT1-T2 Oral Cavity Squamous Cell Carcinoma.
    Robinson EM; Lam AS; Solomon I; Brady JS; Pang J; Faraji F; Houlton JJ; Futran ND; Barber BR
    Laryngoscope; 2022 Oct; 132(10):1962-1970. PubMed ID: 35102568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Positive Surgical Margins in cT3-T4 Oral Cavity Squamous Cell Carcinoma.
    Prasad K; Topf MC; Clookey S; Philips R; Curry J; Tassone P
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1200-1207. PubMed ID: 37232479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal Cavity Squamous Cell Carcinoma: Factors Associated With Treatment Outcomes and Potential Organ Preservation.
    Issa K; Teitelbaum J; Smith BD; Wang F; Ackall F; Sargi Z; Rangarajan SV; Jung SH; Jang DW; Abi Hachem R
    Am J Rhinol Allergy; 2023 Jan; 37(1):35-42. PubMed ID: 36189818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'T4b' or not to 'T4b': addressing the resectability in T4b oral cavity squamous cell carcinoma.
    Joy A; Subash A; Thakur S; Rao V
    Int J Oral Maxillofac Surg; 2022 Dec; 51(12):1605-1606. PubMed ID: 35599081
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Impact of Surgical Resection in Locally Advanced T4b Oral Squamous Cell Carcinoma.
    Gangopadhyay A; Bhatt S; Nandy K; Rai S; Rathod P; Puj KS
    Laryngoscope; 2021 Jul; 131(7):E2266-E2274. PubMed ID: 33459389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Kang CJ; Wen YW; Lee SR; Ng SH; Lee LA; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Tsai CY; Lin CH; Tsao CK; Fang TJ; Huang SF; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    Oral Oncol; 2022 Mar; 126():105750. PubMed ID: 35123256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of Occult Invasive Disease in Patients With Biopsy-Proven Oral Cavity Squamous Cell Carcinoma in Situ.
    Cooper DJ; Ziemba Y; Pereira L; Kann BH; Parashar B; Miles BA; Ghaly M; Seetharamu N; Frank D; Talcott WJ
    JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):151-156. PubMed ID: 38175664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients.
    Liao CT; Wen YW; Lee SR; Liu TW; Tsai ST; Tsai MH; Lin JC; Lou PJ; Chu PY; Leu YS; Tsai KY; Terng SD; Chen TM; Wang CH; Chien CY; Chen WC; Lee LY; Lin CY; Wang HM; Ng SH; Lin CH; Fang TJ; Huang SF; Kang CJ; Chang KP; Yang LY; Yen TC;
    Ann Surg Oncol; 2017 Mar; 24(3):785-793. PubMed ID: 27896513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative outcomes in oral cavity cancer with resected pT4a and pT4b.
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Chen IH; Chang KP; Huang SF; Kang CJ; Fang KH; Wang YC; Chang YL; Huang YC; Tsai CY; Yen TC
    Oral Oncol; 2013 Mar; 49(3):230-6. PubMed ID: 23063612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in Elderly Patients.
    Pollom EL; Chin AL; Lee NY; Tsai CJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):758-766. PubMed ID: 28366574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative Radiotherapy and Survival in Oral Cavity Squamous Cell Carcinoma With Mandibulectomy.
    Harley RJ; Iheagwara UK; Faraji F; Sridharan S; Kubik MW
    JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):233-239. PubMed ID: 38300601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy improves survival in pT4aN0 oral cavity squamous cell carcinoma with bone invasion.
    Stanford-Moore GB; Sola AM; Chan J; El-Sayed I; George J; Ha P; Ryan WR; Heaton CM
    Am J Otolaryngol; 2022; 43(2):103303. PubMed ID: 34894450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.